Full Text View
Tabular View
Study Results
Related Studies
Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients
This study has been completed.
Study NCT00770146   Information provided by Genzyme

First Received on October 8, 2008.   Last Updated on February 15, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypercholesterolemia
Coronary Heart Disease
Additional conditions recognized in this trial
Coronary Artery Disease
Coronary Disease
Heart Diseases
Myocardial Ischemia
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Dyslipidemias
Hyperlipidemias
Lipid Metabolism Disorders
Metabolic Diseases
Vascular Diseases
Interventions listed in this trial
Mipomersen sodium
Placebo
Sponsors listed in this trial
Genzyme
Isis Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services